Lupin Ltd

LUPIN10 Dec 2024
Pharmaceuticals
+20.30 (+0.96%)
Lowest Today
Highest Today
Today’s Open
Prev. Close
52 Week High
52 Week Low
To Invest in Lupin Ltd
Lupin Ltd
Pharmaceuticals
LUPIN10 Dec 2024
+20.30 (+0.96%)
1D
1M
6M
1Y
5Y
All

Lupin Ltd - Share Price & Details

Traded Volume
Market Cap(Cr)
Avg Traded Price
1 Year return
71.16%
Upper Circuit
Lower Circuit
P/E TTM
32.06
P/B Ratio
4.37
Traded Value(Cr)
0.13
EPS TTM
65.71
Book value
Dividend
0.38%

Invest in Lupin Ltd at ZERO Brokerage for 30 days

Price Performance

1.70 %
1 Wk
0.95 %
1 M
-5.06 %
3 M
71.16 %
1 Y
60.32 %
YTD

Traded Volume Movement

Technical Details

Support 3
2087
Support 2
2096
Support 1
2111
Pivot Point :
2120
Resistance 1
2135
Resistance 2
2145
Resistance 3
2159

Peer Comparison

Scrip NamePriceDaily ChangeM.Cap (Cr)1 Year Returns %P/E (TTM)PB Ratio
Lupin Ltd
₹2,125.00(+20.30/0.96%)
2,125.00+20.3096,015.9071.1632.064.37
Alembic Pharmaceuticals Ltd
₹1,107.70(+5.15/0.47%)
1,107.70+5.1521,672.0743.9028.294.31
Ipca Laboratories Ltd
₹1,539.65(+15.90/1.04%)
1,539.65+15.9038,658.1837.4255.435.74
J B Chemicals & Pharmaceuticals Ltd
₹1,777.35(-5.30/-0.30%)
1,777.35-5.3027,704.1122.1046.188.78
386.05+2.852,249.59-14.1122.431.36
Sanofi India Ltd
₹6,251.25(-51.15/-0.81%)
6,251.25-51.1514,514.43-22.7034.3721.16

About Lupin Ltd

Lupin Ltd is in the Pharmaceuticals sector, having a market capitalization of Rs. 96104.86 crores. It has reported a sales of Rs. 3931.73 crores and a net profit of Rs. 807.76 crores for the quarter ended December 2018. The company management includes M D Gupta, M D Gupta,Nilesh Deshbandhu Gupta.,Vinita Gupta,R V Satam,Jean-Luc Belingard,Ramesh Swaminathan,Mark D McDade,K B S Anand,Punita Kumar Sinha,Jeffrey Kindler,Alfonso Zulueta (Lupin Ltd) among others.
Chairman
M D Gupta
Registered office
Kalpataru Inspire 3rd Floor,Off Western Exp HW Santacruz-E,Mumbai,Maharashtra,400055
FAX :91-22-6640 8131
Background
Incorporation Year1983
Face Value₹2
Market Lot1

Latest News

📢 Benchmark indices open on a flat note today; Nifty near 24,630

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 25.14 points or 0.03% at 81,533.60 and the Nifty was up 6.75 points or 0.03% at 24,625.75. 📢IRB Infra (⬆️1.94%), BEL (⬆️0.94%) and Power Grid Corporation (⬆️0.81%) appeared as the top performers on the Nifty50 at open. Tata Motors, BEL, Syngene International stocks are in focus today.
10 Dec 2024 | 09:22 AM

📢 Benchmark indices open on a flat note today; Nifty near 24,630

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 25.14 points or 0.03% at 81,533.60 and the Nifty was up 6.75 points or 0.03% at 24,625.75. 📢IRB Infra (⬆️1.94%), BEL (⬆️0.94%) and Power Grid Corporation (⬆️0.81%) appeared as the top performers on the Nifty50 at open. Tata Motors, BEL, Syngene International stocks are in focus today.
10 Dec 2024 | 09:22 AM

📢 Benchmark indices open on a flat note today; Nifty near 24,630

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 25.14 points or 0.03% at 81,533.60 and the Nifty was up 6.75 points or 0.03% at 24,625.75. 📢IRB Infra (⬆️1.94%), BEL (⬆️0.94%) and Power Grid Corporation (⬆️0.81%) appeared as the top performers on the Nifty50 at open. Tata Motors, BEL, Syngene International stocks are in focus today.
10 Dec 2024 | 09:22 AM

📢 Benchmark indices open on a flat note today; Nifty near 24,630

📈 Amid mixed global cues, benchmark indices started on a flat note today.
📊 At 9:16 AM, the Sensex gained 25.14 points or 0.03% at 81,533.60 and the Nifty was up 6.75 points or 0.03% at 24,625.75. 📢IRB Infra (⬆️1.94%), BEL (⬆️0.94%) and Power Grid Corporation (⬆️0.81%) appeared as the top performers on the Nifty50 at open. Tata Motors, BEL, Syngene International stocks are in focus today.
10 Dec 2024 | 09:22 AM

Glenmark Pharma surges 4%, why?

Shares of Glenmark Pharma surged over 4% in early trade on December 10 after the company stated that the first clinical data of its blood cancer drug showed a positive response rate of 83%.  The positive development, essential for the successful clinical trial of Glenmark's blood cancer drug, bolstered sentiment for the stock.
10 Dec 2024 | 10:21 AM

How to buy Lupin Ltd shares on nse?

To buy Lupin Ltd shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Lupin Ltd share price today?

The Lupin Ltd shares price on nse is Rs.2125 today.

What is the market cap of Lupin Ltd shares on NSE ?

The company has a market capitalization of Rs.96015.90Cr

What is the PE & PB ratio of Lupin Ltd shares ?

PE is 32.06 and PB is 4.37

What is the 52 Week High and Low of Lupin Ltd shares?

Lupin Ltd stock price high: Rs.2312 Lupin Ltd stock price low: Rs.1200.15

What can be the price of Lupin stocks on BSE?

As of 13:15 hours on 12th May 2023, the stock price of Lupin on the BSE was rupees 773. The price fluctuates constantly throughout trading hours. So, check for the updated price when you invest.

Is it safe to buy Lupin stocks?

Lupin is a leading name in the pharmaceutical sector. It has a market capitalization of rupees 34,804.93 crores with an average trading volume of 61,434.45. The stock might suffer price fluctuations in the short-run depending on market movements. However, the stock price might appreciate and give good returns over the long term. So, it is safe to invest in Lupin if you have a long-term horizon.

What is the current market value per stock of Lupin stocks?

As of 13:15 hours on 12th May 2023, the current market value is rupees 773 on the BSE and rupees 773.10 on the NSE.

Does Lupin have any debts?

Yes, Lupin has debt in its balance sheet. As of 31st March 2023, Lupin had secured loans worth rupees 613.46 crores.

Will Lupin's stock price increase?

While Lupin is trading at rupees 773 on 12th May 2023, its lower circuit is quoted at rupees 688.45, and the upper circuit is at rupees 841.35. Considering the upper circuit, the company’s stock price is expected to increase. Moreover, if you stay invested over a long-term horizon, you can witness a gain in the stock price as the short-term volatilities smoothen out and the company grows.

What is the business plan of Lupin?

Lupin aims to expand its domestic and international business with increased manufacturing of its popular drugs. The company specifically targeted growth in the US and China which would boost its revenue and profitability.

Click here to see your activities